Cutaneous Melanoma
📧 Sign up to get email alerts when something new happens for Cutaneous Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: Stereotactic Radiosurgery and Immune Checkpoint Inhibitors With NovoTTF-200M for the Treatment of Melanoma Brain Metastases [Phase 1]
Phase 1 trial evaluating stereotactic radiosurgery, NovoTTF-200M, and immune checkpoint inhibitors for melanoma brain metastases was termina…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Phase 1 Study of PF-08046033 in Advanced Solid Tumors [Phase 1]
Pfizer is evaluating PF-08046033 in a Phase 1 trial for adults with advanced solid tumors, including non-small cell lung cancer, esophageal …
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: The Multicentre Selective Lymphadenectomy Trial - 3 [NA]
The multicentre trial evaluating selective lymphadenectomy for stage III cutaneous melanoma is currently recruiting at multiple centers.
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: Aerosolized Aldesleukin in Treating Patients With Lung Metastases [Phase 1]
Phase 1 study evaluating aerosolized aldesleukin (interleukin-2) in patients with cancers that have metastasized to the lung, including mela…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma [Phase 3]
Phase 3 clinical trial evaluating SUPRAME-ACTengine IMA203 versus investigator's choice of treatment in previously treated, unresectable or …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-20Clinical Trial Update: A Study of PF-08046049/SGN-BB228 in Advanced Melanoma and Other Solid Tumors [Phase 1]
This clinical trial update describes a Phase 1 study of PF-08046049/SGN-BB228 in advanced melanoma and other solid tumors, with the conditio…
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: Dose Finding Study of TNO155 in Adult Patients With Advanced Solid Tumors [Phase 1]
Novartis' Phase 1 dose-finding trial of TNO155 in adults with advanced solid tumors has been terminated. No efficacy results are provided in…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma [Phase 2, Phase 3]
This clinical trial update describes a Phase II/III study of the combination nivolumab, ipilimumab, and GM-CSF in patients with advanced cut…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating immunotherapy in combination with prednisone and sirolimus for kidney transplant recipients with unresectable or …
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study Evaluating Whether Pembrolizumab Alone or in Combination With CMP-001 Improves Efficacy of Treatment in Patients With Operable Melanoma [Phase 2]
A Phase 2 clinical trial update evaluating pembrolizumab alone or in combination with CMP-001 for operable melanoma, including melanoma of u…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Cediranib Maleate and Selumetinib Sulfate in Treating Patients With Solid Malignancies [Phase 1]
Phase 1 trial update evaluating cediranib maleate and selumetinib sulfate in patients with solid malignancies, including metastatic melanoma…
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: MoleMapper, Visiomed, and Confocal Microscopy in Screening Participants for Melanoma [NA]
The clinical trial evaluating MoleMapper, Visiomed, and confocal microscopy for melanoma screening has been terminated.
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Study of the Effectiveness and Safety of Acasunlimab Alone and With Pembrolizumab to Treat Advanced Melanoma of the Skin That Has Returned After Treatment With an Approved Checkpoint Inhibitor Therapy (ABBIL1TY MELANOMA-07) [Phase 2]
A Phase 2 trial evaluating Acasunlimab alone and in combination with pembrolizumab for advanced melanoma that has relapsed after prior check…
-
CLINICAL_TRIALS trial_result · 2026-04-02Clinical Trial Update: Proof of Concept of TBio-4101, Lymphodepleting Chemo, IL-2 for Relapsed/Refractory Melanoma [Phase 1]
Phase 1 trial update reports proof of concept for TBio-4101 in combination with lymphodepleting chemotherapy and IL-2 for relapsed/refractor…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Testing the Addition of the Anti-cancer Drug, Tazemetostat, to the Usual Treatment (Dabrafenib and Trametinib) for Metastatic Melanoma That Has Progressed on the Usual Treatment [Phase 1, Phase 2]
A Phase 1/2 trial is evaluating whether adding tazemetostat to dabrafenib and trametinib improves outcomes in patients with metastatic melan…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer [Phase 1, Phase 2]
A clinical trial update for AU-007, a monoclonal antibody that binds IL-2 and inhibits IL-2Rα binding, being studied in unresectable locally…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Exercise to Boost Response to Checkpoint Blockade Immunotherapy [NA]
Clinical trial update describes an active-not-recruiting study investigating whether exercise can boost response to checkpoint blockade immu…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors [Phase 1]
A Phase 1 trial evaluating donor natural killer cells with cyclophosphamide and etoposide in children and young adults with relapsed or refr…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Ketogenic Dietary Intervention to Improve Response to Immunotherapy in Patients With Metastatic Melanoma and Metastatic Kidney Cancer [NA]
This clinical trial update notes a study evaluating whether a ketogenic diet can improve response to immunotherapy in patients with metastat…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Sonidegib and Pembrolizumab in Treating Patients With Advanced Solid Tumors [Phase 1]
This update reports on a Phase 1 trial testing the combination of sonidegib and pembrolizumab in patients with various advanced solid tumors…
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: Bintrafusp Alfa and Pimasertib for the Treatment of Patients With Brain Metastases [Phase 1, Phase 2]
A Phase 1/2 trial evaluating Bintrafusp alfa in combination with Pimasertib for brain metastases has been terminated, with results posted in…
-
CLINICAL_TRIALS trial_result · 2026-03-13Clinical Trial Update: Atorvastatin for Preventing Disease Metastasis in Patients With Resected High-Risk Stage IIA, IIB, or IIIA Melanoma [Phase 2]
A Phase 2 trial is evaluating atorvastatin to prevent metastasis in patients with resected high-risk cutaneous melanoma (stages IIA, IIB, II…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer [Phase 1]
A Phase 1 clinical trial at MD Anderson Cancer Center is studying whether modifying the gut microbiome via fecal transplantation can reduce …
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: EMLA Topical Cream for Treatment of Pain in Patients Receiving Intra-Dermal Technetium 99 Injections for Lymphoscintigraphy for Skin Cancers [Phase 2]
Phase 2 clinical trial evaluating EMLA Topical Cream to reduce pain from intradermal Tc-99 injections used for lymphoscintigraphy in patient…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: Intralesional Influenza Vaccine for the Treatment of Stage I-IV Melanoma [Phase 1]
Phase 1 trial evaluating an intralesional influenza vaccine for treating stage I-IV cutaneous melanoma; the study is currently recruiting.